VERIFY the role of initial combination therapy in patients with type 2 diabetes - PubMed (original) (raw)
Comment
. 2019 Oct 26;394(10208):1483-1485.
doi: 10.1016/S0140-6736(19)32165-8. Epub 2019 Sep 18.
Affiliations
- PMID: 31542294
- DOI: 10.1016/S0140-6736(19)32165-8
Comment
VERIFY the role of initial combination therapy in patients with type 2 diabetes
Ofri Mosenzon et al. Lancet. 2019.
No abstract available
Comment on
- Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial.
Matthews DR, Paldánius PM, Proot P, Chiang Y, Stumvoll M, Del Prato S; VERIFY study group. Matthews DR, et al. Lancet. 2019 Oct 26;394(10208):1519-1529. doi: 10.1016/S0140-6736(19)32131-2. Epub 2019 Sep 18. Lancet. 2019. PMID: 31542292 Clinical Trial.
Similar articles
- In type 2 diabetes, early metformin plus vildagliptin reduced treatment failure vs a stepwise approach.
Brown K, Donato AA. Brown K, et al. Ann Intern Med. 2020 Feb 18;172(4):JC23. doi: 10.7326/ACPJ202002180-023. Ann Intern Med. 2020. PMID: 32066156 No abstract available. - Efficacy and tolerability of vildagliptin vs. pioglitazone when added to metformin: a 24-week, randomized, double-blind study.
Bolli G, Dotta F, Rochotte E, Cohen SE. Bolli G, et al. Diabetes Obes Metab. 2008 Jan;10(1):82-90. doi: 10.1111/j.1463-1326.2007.00820.x. Epub 2007 Nov 22. Diabetes Obes Metab. 2008. PMID: 18034842 Clinical Trial. - Effects of vildagliptin on glucose control over 24 weeks in patients with type 2 diabetes inadequately controlled with metformin.
Bosi E, Camisasca RP, Collober C, Rochotte E, Garber AJ. Bosi E, et al. Diabetes Care. 2007 Apr;30(4):890-5. doi: 10.2337/dc06-1732. Epub 2007 Feb 2. Diabetes Care. 2007. PMID: 17277036 Clinical Trial. - Combination therapy with metformin plus vildagliptin in type 2 diabetes mellitus.
Guarino E, Nigi L, Patti A, Fondelli C, Dotta F. Guarino E, et al. Expert Opin Pharmacother. 2012 Jun;13(9):1377-84. doi: 10.1517/14656566.2012.667078. Epub 2012 Mar 7. Expert Opin Pharmacother. 2012. PMID: 22397507 Review. - Translating science into clinical practice: focus on vildagliptin in combination with metformin.
Barnett AH. Barnett AH. Diabetes Obes Metab. 2009 May;11 Suppl 2:18-26. doi: 10.1111/j.1463-1326.2008.01030.x. Diabetes Obes Metab. 2009. PMID: 19385980 Review.
Cited by
- From glucose lowering agents to disease/diabetes modifying drugs: a "SIMPLE" approach for the treatment of type 2 diabetes.
Mosenzon O, Del Prato S, Schechter M, Leiter LA, Ceriello A, DeFronzo RA, Raz I. Mosenzon O, et al. Cardiovasc Diabetol. 2021 Apr 28;20(1):92. doi: 10.1186/s12933-021-01281-y. Cardiovasc Diabetol. 2021. PMID: 33910583 Free PMC article. Review. - Evaluating the Evidence behind the Novel Strategy of Early Combination from Vision to Implementation.
Paldánius PM. Paldánius PM. Diabetes Metab J. 2020 Dec;44(6):785-801. doi: 10.4093/dmj.2020.0179. Epub 2020 Sep 15. Diabetes Metab J. 2020. PMID: 33081426 Free PMC article. Review. - Insights from VERIFY: Early Combination Therapy Provides Better Glycaemic Durability Than a Stepwise Approach in Newly Diagnosed Type 2 Diabetes.
Matthews D, Del Prato S, Mohan V, Mathieu C, Vencio S, Chan JCN, Stumvoll M, Paldánius PM. Matthews D, et al. Diabetes Ther. 2020 Nov;11(11):2465-2476. doi: 10.1007/s13300-020-00926-7. Epub 2020 Sep 25. Diabetes Ther. 2020. PMID: 32975711 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical